157 related articles for article (PubMed ID: 7833471)
21. T-cell-directed TAL-1 expression induces T-cell malignancies in transgenic mice.
Condorelli GL; Facchiano F; Valtieri M; Proietti E; Vitelli L; Lulli V; Huebner K; Peschle C; Croce CM
Cancer Res; 1996 Nov; 56(22):5113-9. PubMed ID: 8912842
[TBL] [Abstract][Full Text] [Related]
22. Erythropoietin stimulates transcription of the TAL1/SCL gene and phosphorylation of its protein products.
Prasad KS; Jordan JE; Koury MJ; Bondurant MC; Brandt SJ
J Biol Chem; 1995 May; 270(19):11603-11. PubMed ID: 7744799
[TBL] [Abstract][Full Text] [Related]
23. Lineage-restricted regulation of the murine SCL/TAL-1 promoter.
Bockamp EO; McLaughlin F; Murrell AM; Göttgens B; Robb L; Begley CG; Green AR
Blood; 1995 Aug; 86(4):1502-14. PubMed ID: 7632958
[TBL] [Abstract][Full Text] [Related]
24. Site-specific deletions involving the tal-1 and sil genes are restricted to cells of the T cell receptor alpha/beta lineage: T cell receptor delta gene deletion mechanism affects multiple genes.
Breit TM; Mol EJ; Wolvers-Tettero IL; Ludwig WD; van Wering ER; van Dongen JJ
J Exp Med; 1993 Apr; 177(4):965-77. PubMed ID: 8459224
[TBL] [Abstract][Full Text] [Related]
25. Control of erythroid cell production via caspase-mediated cleavage of transcription factor SCL/Tal-1.
Zeuner A; Eramo A; Testa U; Felli N; Pelosi E; Mariani G; Srinivasula SM; Alnemri ES; Condorelli G; Peschle C; De Maria R
Cell Death Differ; 2003 Aug; 10(8):905-13. PubMed ID: 12867998
[TBL] [Abstract][Full Text] [Related]
26. T-cell acute lymphoblastic leukemia and the associated basic helix-loop-helix gene SCL/tal.
Goldfarb AN; Greenberg JM
Leuk Lymphoma; 1994 Jan; 12(3-4):157-66. PubMed ID: 8167548
[TBL] [Abstract][Full Text] [Related]
27. Tal-1 induces T cell acute lymphoblastic leukemia accelerated by casein kinase IIalpha.
Kelliher MA; Seldin DC; Leder P
EMBO J; 1996 Oct; 15(19):5160-6. PubMed ID: 8895560
[TBL] [Abstract][Full Text] [Related]
28. Involvement of the putative hematopoietic transcription factor SCL in T-cell acute lymphoblastic leukemia.
Aplan PD; Lombardi DP; Reaman GH; Sather HN; Hammond GD; Kirsch IR
Blood; 1992 Mar; 79(5):1327-33. PubMed ID: 1311214
[TBL] [Abstract][Full Text] [Related]
29. c-tal, a helix-loop-helix protein, is juxtaposed to the T-cell receptor-beta chain gene by a reciprocal chromosomal translocation: t(1;7)(p32;q35).
Fitzgerald TJ; Neale GA; Raimondi SC; Goorha RM
Blood; 1991 Nov; 78(10):2686-95. PubMed ID: 1824262
[TBL] [Abstract][Full Text] [Related]
30. Enhancer-binding activity of the tal-1 oncoprotein in association with the E47/E12 helix-loop-helix proteins.
Hsu HL; Cheng JT; Chen Q; Baer R
Mol Cell Biol; 1991 Jun; 11(6):3037-42. PubMed ID: 2038315
[TBL] [Abstract][Full Text] [Related]
31. Two distinct mechanisms for the SCL gene activation in the t(1;14) translocation of T-cell leukemias.
Bernard O; Guglielmi P; Jonveaux P; Cherif D; Gisselbrecht S; Mauchauffe M; Berger R; Larsen CJ; Mathieu-Mahul D
Genes Chromosomes Cancer; 1990 Jan; 1(3):194-208. PubMed ID: 1964581
[TBL] [Abstract][Full Text] [Related]
32. GATA-and SP1-binding sites are required for the full activity of the tissue-specific promoter of the tal-1 gene.
Lecointe N; Bernard O; Naert K; Joulin V; Larsen CJ; Romeo PH; Mathieu-Mahul D
Oncogene; 1994 Sep; 9(9):2623-32. PubMed ID: 8058326
[TBL] [Abstract][Full Text] [Related]
33. Does activation of the TAL1 gene occur in a majority of patients with T-cell acute lymphoblastic leukemia? A pediatric oncology group study.
Bash RO; Hall S; Timmons CF; Crist WM; Amylon M; Smith RG; Baer R
Blood; 1995 Jul; 86(2):666-76. PubMed ID: 7605997
[TBL] [Abstract][Full Text] [Related]
34. Measurement of SIL-TAL1 fusion gene transcripts associated with human T-cell lymphocytic leukemia by real-time reverse transcriptase-PCR.
Curry JD; Smith MT
Leuk Res; 2003 Jul; 27(7):575-82. PubMed ID: 12681356
[TBL] [Abstract][Full Text] [Related]
35. An scl gene product lacking the transactivation domain induces bony abnormalities and cooperates with LMO1 to generate T-cell malignancies in transgenic mice.
Aplan PD; Jones CA; Chervinsky DS; Zhao X; Ellsworth M; Wu C; McGuire EA; Gross KW
EMBO J; 1997 May; 16(9):2408-19. PubMed ID: 9171354
[TBL] [Abstract][Full Text] [Related]
36. SCL gene in human tumors.
Rockman S; Begley CG; Kannourakis G; Mann GJ; Dobrovic AN; Kefford RF; McGrath K
Leukemia; 1992 Jul; 6(7):623-5. PubMed ID: 1625484
[TBL] [Abstract][Full Text] [Related]
37. Defects of the mismatch repair gene MSH2 are implicated in the development of murine and human lymphoblastic lymphomas and are associated with the aberrant expression of rhombotin-2 (Lmo-2) and Tal-1 (SCL).
Lowsky R; DeCoteau JF; Reitmair AH; Ichinohasama R; Dong WF; Xu Y; Mak TW; Kadin ME; Minden MD
Blood; 1997 Apr; 89(7):2276-82. PubMed ID: 9116269
[TBL] [Abstract][Full Text] [Related]
38. The HRX proto-oncogene product is widely expressed in human tissues and localizes to nuclear structures.
Butler LH; Slany R; Cui X; Cleary ML; Mason DY
Blood; 1997 May; 89(9):3361-70. PubMed ID: 9129043
[TBL] [Abstract][Full Text] [Related]
39. Cloning and characterization of the SIL promoter.
Colaizzo-Anas T; Aplan PD
Biochim Biophys Acta; 2003 Jan; 1625(2):207-13. PubMed ID: 12531481
[TBL] [Abstract][Full Text] [Related]
40. The T cell leukemia oncoprotein SCL/tal-1 is essential for development of all hematopoietic lineages.
Porcher C; Swat W; Rockwell K; Fujiwara Y; Alt FW; Orkin SH
Cell; 1996 Jul; 86(1):47-57. PubMed ID: 8689686
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
